Co-administration of amoxicillin-loaded chitosan nanoparticles and inulin: A novel strategy for mitigating antibiotic resistance and preserving microbiota balance in Helicobacter pylori treatment
- PMID: 37673144
- DOI: 10.1016/j.ijbiomac.2023.126706
Co-administration of amoxicillin-loaded chitosan nanoparticles and inulin: A novel strategy for mitigating antibiotic resistance and preserving microbiota balance in Helicobacter pylori treatment
Abstract
Helicobacter pylori (H. pylori) is a causative agent of various gastrointestinal diseases and eradication mainly relies on antibiotic treatment, with (AMX) being a key component. However, rising antibiotic resistance in H. pylori necessitates the use of antibiotics combination therapy, often disrupting gut microbiota equilibrium leading to further health complications. This study investigates a novel strategy utilizing AMX-loaded chitosan nanoparticles (AMX-CS NPs), co-administered with prebiotic inulin to counteract H. pylori infection while preserving microbiota health. Following microbroth dilution method, AMX displayed efficacy against H. pylori, with a MIC50 of 48.34 ± 3.3 ng/mL, albeit with a detrimental impact on Lactobacillus casei (L. casei). The co-administration of inulin (500 μg/mL) with AMX restored L. casei viability while retaining the lethal effect on H. pylori. Encapsulation of AMX in CS-NPs via ionic gelation method, resulted in particles of 157.8 ± 3.85 nm in size and an entrapment efficiency (EE) of 86.44 ± 2.19 %. Moreover, AMX-CS NPs showed a sustained drug release pattern over 72 h with no detectable toxicity on human dermal fibroblasts cell lines. Encapsulation of AMX into CS NPs also reduced its MIC50 against H. pylori, while its co-administration with inulin maintained L. casei viability. Interestingly, treatment with AMX-CS NPs also reduced the expression of the efflux pump gene hefA in H. pylori. This dual treatment strategy offers a promising approach for more selective antimicrobial treatment, minimizing disruption to healthy microbial communities while effectively addressing pathogenic threats.
Keywords: Amoxicillin; Antibiotic resistance; Chitosan nanoparticles; H. pylori; Inulin; L. casei; hefA.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.
Similar articles
-
Metal-Based Nanoparticles: A Prospective Strategy for Helicobacter pylori Treatment.Int J Nanomedicine. 2023 May 9;18:2413-2429. doi: 10.2147/IJN.S405052. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37192898 Free PMC article. Review.
-
Bacteria-targeting chitosan/carbon dots nanocomposite with membrane disruptive properties improve eradication rate of Helicobacter pylori.J Biomater Sci Polym Ed. 2021 Dec;32(18):2423-2447. doi: 10.1080/09205063.2021.1972559. Epub 2021 Oct 23. J Biomater Sci Polym Ed. 2021. PMID: 34644235
-
Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of Helicobacter pylori.ACS Appl Mater Interfaces. 2020 Dec 9;12(49):54316-54327. doi: 10.1021/acsami.0c13101. Epub 2020 Nov 25. ACS Appl Mater Interfaces. 2020. PMID: 33236884
-
Development of Helicobacter pylori treatment: How do we manage antimicrobial resistance?World J Gastroenterol. 2019 Apr 28;25(16):1907-1912. doi: 10.3748/wjg.v25.i16.1907. World J Gastroenterol. 2019. PMID: 31086459 Free PMC article. Review.
-
Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori.Colloids Surf B Biointerfaces. 2018 Apr 1;164:11-19. doi: 10.1016/j.colsurfb.2018.01.008. Epub 2018 Jan 9. Colloids Surf B Biointerfaces. 2018. PMID: 29367052
Cited by
-
A Study of the Synergistic Effects of Essential Oils from Origanum compactum and Origanum elongatum with Commercial Antibiotics against Highly Prioritized Multidrug-Resistant Bacteria for the World Health Organization.Metabolites. 2024 Apr 7;14(4):210. doi: 10.3390/metabo14040210. Metabolites. 2024. PMID: 38668338 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical